XT
VIR icon

XTX Topco’s Vir Biotechnology VIR Stock Holding History

XTX Topco’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$600K Buy
66,942
+6,864
+11% +$54.7K 0.01% 1858
2025
Q4 		$362K Sell
60,078
-79,818
-57% -$475K 0.01% 1900
2025
Q3 		$799K Buy
+139,896
New +$715K 0.04% 720
2025
Q1 		– Sell
-24,085
Closed -$177K – 3169
2024
Q4 		$177K Buy
+24,085
New +$190K 0.01% 1605
2024
Q3 		– Sell
-48,399
Closed -$431K – 2649
2024
Q2 		$431K Buy
+48,399
New +$464K 0.04% 732
2023
Q4 		– Sell
-44,205
Closed -$414K – 2193
2023
Q3 		$414K Buy
+44,205
New +$630K 0.07% 514
2023
Q1 		– Sell
-8,096
Closed -$205K – 1681
2022
Q4 		$205K Sell
8,096
-3,358
-29% -$82.3K 0.04% 830
2022
Q3 		$221K Buy
+11,454
New +$291K 0.05% 724

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

XTX Topco's VIR Position: Q1 2026 in Review

XTX Topco increased its Vir Biotechnology (VIR) stake by 11% in Q1 2026, buying an estimated $54.7K and bringing the position to 66,942 shares worth $600K. The position accounts for 0.01% of the portfolio, ranked #1858.

XTX Topco first reported a position in VIR in Q3 2022 and has held it in 8 quarters since. The position peaked at $799K in Q3 2025. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • XTX Topco held 66,942 shares of Vir Biotechnology worth $600K as of Q1 2026.
  • XTX Topco bought 6,864 Vir Biotechnology shares in Q1 2026, an estimated $54.7K.
  • Vir Biotechnology made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1858 holding.
  • XTX Topco first reported a position in Vir Biotechnology in Q3 2022 and has held it in 8 quarters since.
  • XTX Topco's Vir Biotechnology position peaked at $799K in Q3 2025.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.